Vilin Bio Med (NSE:VILINBIO) COGS-to-Revenue : 0.63 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med COGS-to-Revenue?

Vilin Bio Med's Cost of Goods Sold for the six months ended in Sep. 2023 was ₹48.30 Mil. Its Revenue for the six months ended in Sep. 2023 was ₹76.46 Mil.

Vilin Bio Med's COGS to Revenue for the six months ended in Sep. 2023 was 0.63.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Vilin Bio Med's Gross Margin % for the six months ended in Sep. 2023 was 36.82%.

Vilin Bio Med COGS-to-Revenue Historical Data

The historical data trend for Vilin Bio Med's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med COGS-to-Revenue Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

COGS-to-Revenue

0.83

0.79

0.81

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
COGS-to-Revenue	-	-	-	0.59	0.63

Vilin Bio Med COGS-to-Revenue Calculation

Vilin Bio Med's COGS to Revenue for the fiscal year that ended in Mar. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	90.868	/	112.149
	=	0.81

Vilin Bio Med's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	48.304	/	76.457
	=	0.63

Vilin Bio Med (NSE:VILINBIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Vilin Bio Med's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	48.304 / 76.457
	=	36.82 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Vilin Bio Med COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines